Chronic Obstructive Pulmonary Disorder (COPD) News and Research

Latest Chronic Obstructive Pulmonary Disorder (COPD) News and Research

Patients with COPD show improvements in lung function with olodaterol

Data from the olodaterol Phase 3 clinical program, presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, showed the addition of olodaterol 5 and 10 µg delivered once daily via the Respimat® inhaler provided improvements in lung function in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

10 Sep 2013

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

Novartis announced new analyses of data for once-daily Ultibro® Breezhaler® (investigational QVA149 - indacaterol 85 mcg/glycopyrronium 43 mcg delivered dose, equivalent to 110 mcg/50 mcg metered dose per capsule), which showed significant improvements in lung function, shortness of breath and health-related quality of life for chronic obstructive pulmonary disease (COPD) patients versus all comparators1,2. These data were part of 39 respiratory abstracts presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.

9 Sep 2013

"Leukotriene B4" play opposing roles in turning inflammation on and off for allergic asthma, COPD

Bethesda, MD-Japanese researchers have made a new step toward understanding why-and how to stop-runaway inflammation for both chronic obstructive pulmonary disorder (COPD) and allergic asthma. In a new report appearing in the August 2013 issue of The FASEB Journal scientists show that two receptors of an inflammatory molecule, called "leukotriene B4," play opposing roles in turning inflammation on and off for allergic asthma and COPD.

2 Aug 2013

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

A group of Australian researchers, back in 2006, noted that there was a link between the severity of cystic fibrosis between sufferers who surfed, and sufferers who did not surf – and obviously Australia is a good place to spot that.

4 Jul 2013

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from AUGMENT/COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) for the treatment of Chronic Obstructive Pulmonary Disease (COPD), delivered in the Pressair™ inhaler (Genuair® outside the USA).

2 May 2013

UK’s health performance: an interview with Prof. Murray, University of Washington

Rates of premature mortality in the UK have been falling steadily, but the pace of decline is not as fast as in many other high-income countries, such as Australia. In that sense, the UK lags behind.

29 Apr 2013

COPD phase III study by Almirall and Forest Laboratories announces positive results

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall’s inhaler Genuair® (Pressair™ in the USA).

16 Apr 2013

£1.2 billion over five years to be saved with Telehealth roll out in UK

Telehealth or telecare in health may soon allow people with long term conditions like heart disease, diabetes and chronic obstructive pulmonary disorder (COPD) to manage their illness largely from home feel authorities.

8 Mar 2012

Volunteers needed in worldwide study to help people breathe easier

Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this month, assessing a potential new treatment.

26 Jul 2011

New paper provides unique review on respiratory disorders in the Middle East

Lung diseases in the Middle East range from the centuries-old pulmonary tuberculosis (TB) to modern manifestations caused by chemical warfare. A new paper now available in Respirology, a journal of the Asian Pacific Society of Respirology, provides pulmonologists and patients with the first comprehensive review of respiratory illnesses specific to the Persian Gulf region, and the challenges in treating them.

14 Jul 2011

Study finds inhaled corticosteroids increase type 2 diabetes risk

Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.

2 Nov 2010

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

Clinical Data, Inc. today announced operational and financial results for the first quarter ended June 30, 2010, noting key accomplishments including the acceptance of the Company's new drug application (NDA) for vilazodone by the U.S. Food and Drug Administration (FDA) and the successful completion of a public offering .

9 Aug 2010

Wireless monitoring system for people with debilitating conditions

A wireless monitoring system for people with debilitating conditions such as Parkinson's disease or chronic obstructive pulmonary disorder could allow healthcare workers to assess a patient's health and the development of their disease without hindering their movements. Details of the system are reported in the International Journal of Biomedical Engineering and Technology.

27 May 2010

Self-treatment lowers overall health care costs for chronic obstructive pulmonary disorder sufferers

Individuals suffering from chronic obstructive pulmonary disorder (COPD) can experience significant savings in healthcare costs by employing a self-treatment program with the judicious use of medications, according to the results of a new study. The self-treatment program achieves these savings by reducing the duration of flare-ups.

17 May 2009

Body's defenses may worsen chronic obstructive pulmonary disorder

Although the immune system is designed to protect the body from harm, it may actually worsen one of the most difficult-to-treat respiratory diseases: chronic obstructive pulmonary disorder (COPD), according to new University of Cincinnati (UC) research.

9 Feb 2009

Patients to benefit from multi-million pound research funding

NHS patients in North West London will benefit from a multi-million pound research project leading to the rapid introduction of new, effective treatments for a wide range of medical conditions.

27 May 2008

Researchers launch lung cancer screening trial

Scientists are testing a new way of detecting lung cancer at an early stage in people at greatest risk of developing the disease.

9 May 2008

Self-management education for patients with chronic obstructive pulmonary disease

Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies.

17 Oct 2007

Impact of indoor air quality on COPD patients

Poor indoor air quality can significantly worsen health problems in people with chronic obstructive pulmonary disorder (COPD), according to researchers in Scotland. High concentrations of fine particulate pollution - the type of pollution associated with secondhand smoke and, in developing countries, indoor cooking and heating fires - were strongly linked to poorer health status.

3 Sep 2007

Hospital admission rates linked to social deprivation, not quality of GP care

Researchers in London have identified a link between increased hospital admission rates for chronic diseases and high levels of material deprivation in the capital.

16 Feb 2006

Chronic Obstructive Pulmonary Disorder (COPD) News and Research

Latest Chronic Obstructive Pulmonary Disorder (COPD) News and Research

Patients with COPD show improvements in lung function with olodaterol

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

"Leukotriene B4" play opposing roles in turning inflammation on and off for allergic asthma, COPD

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

UK’s health performance: an interview with Prof. Murray, University of Washington

COPD phase III study by Almirall and Forest Laboratories announces positive results

£1.2 billion over five years to be saved with Telehealth roll out in UK

Volunteers needed in worldwide study to help people breathe easier

New paper provides unique review on respiratory disorders in the Middle East

Study finds inhaled corticosteroids increase type 2 diabetes risk

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

Wireless monitoring system for people with debilitating conditions

Self-treatment lowers overall health care costs for chronic obstructive pulmonary disorder sufferers

Body's defenses may worsen chronic obstructive pulmonary disorder

Patients to benefit from multi-million pound research funding

Researchers launch lung cancer screening trial

Self-management education for patients with chronic obstructive pulmonary disease

Impact of indoor air quality on COPD patients

Hospital admission rates linked to social deprivation, not quality of GP care

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Chronic Obstructive Pulmonary Disorder (COPD) News and Research

Latest Chronic Obstructive Pulmonary Disorder (COPD) News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in